483
Bioreliance CorporationFDA 483 - Bioreliance Corporation
Record Details
The FDA inspected BioReliance Corporation, a non-clinical laboratory in Rockville, MD, from August 6-8, 2019. The inspection revealed several deficiencies related to personnel training, responsibility assignment, material retention, and quality assurance unit oversight. These observations indicate a need for improved controls in the firm's operations.
- Company
- Bioreliance Corporation
- Product Type
- Biologics
Open in Dashboard
ID · b0edcd89-77c9-4465-990a-45d7a062c755